CytoMed Therapeutics Ltd (GDTC) stock
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.78+0.01 (+1.18%)
Close on Nov 17, 2026Market cap $9.26MP/E –Yield –
CytoMed Therapeutics cash
Cash and short-term investments held at the end of each period.
CytoMed Therapeutics's cash was 2.10M SGD at Dec 31, 2025. For fiscal 2025 it was 2.10M SGD, down 55.4% from the year before. The highest annual figure on record is 6.22M SGD in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.10M SGD | -55.4% |
| FY2024 | Dec 31, 2024 | 4.70M SGD | -24.5% |
| FY2023 | Dec 31, 2023 | 6.22M SGD | +294.0% |
| FY2022 | Dec 31, 2022 | 1.58M SGD | -37.1% |
| FY2021 | Dec 31, 2021 | 2.51M SGD | +183.8% |
| FY2020 | Dec 31, 2020 | 885.27K SGD | +138.7% |
| FY2019 | Dec 31, 2019 | 370.94K SGD | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 2.10M SGD | -16.6% |
| Q4 FY2024 | Dec 31, 2024 | 4.70M SGD | +430.6% |
| Q4 FY2023 | Dec 31, 2023 | 6.22M SGD | +1577.9% |
| Q4 FY2022 | Dec 31, 2022 | 1.58M SGD | – |
| Q4 FY2021 | Dec 31, 2021 | 2.51M SGD | – |
| Q4 FY2020 | Dec 31, 2020 | 885.27K SGD | – |
| Q4 FY2019 | Dec 31, 2019 | 370.94K SGD | – |
See a number that looks wrong?